Unpacking the "Mind" and "Body" Pathways of the Antidepressant Effect of Qigong in Older Adults: A Pilot Study
- Conditions
- Qigong
- Registration Number
- NCT06804408
- Lead Sponsor
- The Hong Kong Polytechnic University
- Brief Summary
The goals of the study are to explore the neurobiological mechanisms and cognitive benefits of qigong in older adults. The main research questions are:
* Does 12-week qigong training lead to significant enhancement in serum adiponectin, serum BDNF and significant reduction in salivary cortisol?
* Does 12-week qigong training bring significant improvement in global cognitive function?
Participants are older adults aged 60 or above. They were randomly assigned to qigong training, mindfulness training, physical exercise training, or wait-list which all last for 12 weeks. Their changes before and after the 12-week period in depressive symptoms, neurobiological markers, and cognitive functions are assessed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 106
- 60 years or older;
- With mild or severer levels of depressive symptoms as indicated by the Geriatric Depression Scale (GDS-8) scores of 5 or above, or Depression Anxiety and Stress Scale-21 (DASS-21) depression subscale scores of 4 or above
- Self-identified as physically stable and without life-threatening diseases.
- With a history of practicing or receiving training of any form of mind-body or regular exercises (including tai chi, yoga, and qigong, or regular physical activity > 3 times/week) during the month prior to study enrollment
- Having changed medications or the dose of medications prescribed for their health condition in the month prior to study enrollment
- With severe cognitive or language impairment as defined as a score of less than 21 on Montreal Cognitive Assessment (MoCA-5min)
- Undergoing electroconvulsive therapy, psychotherapy, or psychoeducation for a psychological or psychiatric condition
- Unable to demonstrate satisfactory standing balance.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Depressive symptoms Baseline and post-intervention (12 weeks after baseline) The eight-item Patient Health Questionnaire
Global cognitive function Baseline and post-intervention (12 weeks after baseline) Montreal Cognitive Assessment
- Secondary Outcome Measures
Name Time Method Serum adiponectin Baseline and post-intervention (12 weeks after baseline) Collected and assayed through peripheral blood sample
Serum BDNF Baseline and post-intervention (12 weeks after baseline) Collected and assayed through peripheral blood sample
Salivary cortisol Baseline and post-intervention (12 weeks after baseline) Collected and assayed through saliva sample
Attention Baseline and post-intervention (12 weeks after baseline) Attention Network Task; Only collected from participants of Qigong and Waitlist groups
Inhibitory control Baseline and post-intervention (12 weeks after baseline) Attention Network Task; Only collected from participants of Qigong and Waitlist groups
Working memory Baseline and post-intervention (12 weeks after baseline) N-back Task; Only collected from participants of Qigong and Waitlist groups
ERP N2 amplitude Baseline and post-intervention (12 weeks after baseline) ERP data recorded during Attention Network Task and N-back Task; Only collected from participants of Qigong and Waitlist groups
ERP P3 amplitude Baseline and post-intervention (12 weeks after baseline) ERP data recorded during Attention Network Task and N-back Task; Only collected from participants of Qigong and Waitlist groups
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Hong Kong Polytechnic University, Department of Rehabilitation Sciences
ðŸ‡ðŸ‡°Kowloon, Hong Kong